PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatitis |
| Symptom | |chronic infection |
| Sentences | 332 |
| PubMedID- 26097786 | Furthermore, healthy participants were excluded from the study for chronic infection with hepatitis b or c; regular use of tobacco or nicotine-containing products within 3 months of screening; and having a level of aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, or bilirubin >1.5 times the upper limit of normal. |
| PubMedID- 25072145 | chronic infection with hepatitis b virus is a cause of end-stage liver disease and hepatocellular carcinoma (hcc). |
| PubMedID- 20557368 | Two week induction of interferon-beta followed by pegylated interferon alpha-2b and ribavirin for chronic infection with hepatitis c. |
| PubMedID- 22750749 | chronic infection with the hepatitis b and c virus represents a major health problem worldwide, as it is estimated that roughly 400 and 200 million people respectively, are infected by each virus. |
| PubMedID- 22848445 | chronic infection with the hepatitis c virus (hcv) affects an estimated 2–3% of the world's population and is a leading cause of cirrhosis and hepatocellular carcinoma 1. |
| PubMedID- 25888935 | chronic infection with hepatitis c virus (hcv) affects approximately 170 million people worldwide, and it is associated with increased morbidity and mortality secondary to cirrhosis and hepatocarcinoma (hcc) 1. |
| PubMedID- 22792259 | chronic infection with hepatitis c virus (hcv) is considered a major risk for chronic liver failure. |
| PubMedID- 21994866 | chronic infection with hepatitis b and hepatitis c virus coupled with other risk factors such as diabetes, obesity, smoking, and heavy alcohol consumption contribute to this rising incidence 3. |
| PubMedID- 23028319 | chronic infection with hepatitis b virus (hbv) can lead to liver failure and cirrhosis; it is also the leading cause of hepatocellular carcinoma. |
| PubMedID- 22923916 | chronic infection with hepatitis b virus (hbv) is a global public health problem, often called the ‘silent killer’, which eventually leads to liver cirrhosis, decompensated hepatic disease, or hepatocellular carcinoma in 20-40% of patients. |
| PubMedID- 22506050 | chronic infections with hepatitis b virus (hbv) and hepatitis c virus (hcv) are important risk factors of hcc. |
| PubMedID- 20950406 | chronic infection with the hepatitis c virus (hcv) is more prevalent than human immunodeficiency virus (hiv) infection, but more public health resources are allocated to hiv than to hcv. |
| PubMedID- 21914084 | chronic infection with hepatitis c virus (hcv) can induce insulin resistance (ir) in a genotype-dependent manner and contributes to steatosis, progression of fibrosis and resistance to interferon plus ribavirin therapy. |
| PubMedID- 26453548 | In eastern asian countries, including taiwan, chronic infection with hepatitis b virus (hbv) is the dominant risk factor . |
| PubMedID- 24336972 | chronic infection with hepatitis b virus (hbv) is the major risk factor for the development of hcc, while hepatitis b virus x protein (hbx) is essential for hbv-associated hcc. |
| PubMedID- 21994696 | chronic infection with hepatitis c virus (hcv) is associated with significant liver disease and is therefore an important public health problem. |
| PubMedID- 26214306 | Another chronic infection, hepatitis c virus infection, interferes with ccnd1 (cyclin d1) expression and with the cell cycle; similar pathways may be involved in mtb infection . |
| PubMedID- 24133665 | A chronic infection with hepatitis b virus (hbv) results in substantial morbidity and mortality worldwide, claiming up to 1 million deaths annually.1 chronic hepatitis b (chb) can be a silent disease for decades, but cirrhosis, liver failure, and hepatocellular carcinoma (hcc) can be the result of untreated infection.2,3 lamivudine (lam) is the first nucleoside analog approved for treatment of chb, and has been applied globally for chb patients. |
| PubMedID- 26113910 | Incidence of hepatocellular carcinoma in chronic infection with hepatitis b. |
| PubMedID- 23291588 | chronic infection with hepatitis c virus (hcv) is a common cause of liver cirrhosis and cancer. |
| PubMedID- 23433483 | chronic infection with hepatitis b or c viruses and alcohol consumption are considered the most important risk factors for liver cancer. |
| PubMedID- 23872239 | chronic infection with hepatitis c virus (hcv) is a major global health problem; there are approximately 120 to 130 million chronic infections worldwide. |
| PubMedID- 24069039 | chronic infection with hepatitis c virus (hcv) is increasingly recognized as a major global health problem (1, 2). |
| PubMedID- 26139985 | chronic infection with the hepatitis b virus (hbv) is the leading risk factor for the development of hepatocellular carcinoma (hcc). |
| PubMedID- 21994691 | An estimated 75% of all hcc cases are due to chronic infection with hepatitis b (hbv) or hepatitis c (hcv) viruses, and the incidence rate of hcc is predicted to increase in western countries until the 2020s due to hcv infection . |
| PubMedID- 25270965 | Above well-known risk factors for hcc development ranging from various toxins to diseases such as diabetes mellitus, chronic infection with hepatitis b virus and hepatitis c virus (hcv) poses the most serious threat, constituting the cause in more than 80 % of cases. |
| PubMedID- 25309066 | chronic infection with hepatitis b virus (hbv) leads to the development of hepatocellular carcinoma and/or chronic liver failure. |
| PubMedID- 22066022 | Most hccs develop in fibrotic or already cirrhotic liver which are a result of chronic infection with hepatitis b (hbv) or hepatitis c virus (hcv) 1. |
| PubMedID- 22491449 | The mechanisms of induction of liver injury during chronic infection with hepatitis c virus (hcv) are not well understood. |
| PubMedID- 23840771 | The greatest burden of hcc is borne in sub-saharan africa and eastern asia, where chronic infection with hepatitis b virus (hbv) is highly endemic . |
| PubMedID- 25285757 | chronic infection with hepatitis c virus (hcv) may lead to b cell activation and transformation into non-hodgkin lymphoma (nhl). |
| PubMedID- 20821891 | That analysis appeared to have answered an important question that had remained unresolved in medical and biological literatures-namely, does chronic infection with hepatitis b cause male-skewed sex ratios at birth. |
| PubMedID- 23082935 | chronic infections with hepatitis b virus (hbv) and hepatitis c virus (hcv) are associated with serious health risks due to hepatic cirrhosis and hepatocellular carcinoma. |
| PubMedID- 23230035 | Purpose: the pharmacologic properties, clinical efficacy, and safety profile of the first oral protease inhibitor approved for the treatment of chronic infection with hepatitis c virus (hcv) genotype 1 are reviewed. |
| PubMedID- 22577025 | A combination of protein c and retinol-binding protein 4 in serum gave promising preliminary results as candidate biomarkers to distinguish patients at different stages of hepatic fibrosis due to chronic infection with hepatitis c virus (hcv). |
| PubMedID- 22190911 | Innate and adaptive immune systems have important role in the pathogenesis of acute and chronic infection with hepatitis b virus (hbv). |
| PubMedID- 23498824 | Background: chronic infection with hepatitis e virus (hev) has recently been recognized in immunocompromised or immunosuppressed individuals. |
| PubMedID- 26295392 | chronic infection with the hepatitis c virus (hcv) is a leading cause of liver-related mortality worldwide, since it is a major risk factor for the development of cirrhosis and hepatocellular carcinoma (hcc) 1. |
| PubMedID- 24727952 | The majority of those infected develop chronic infection, leading to chronic hepatitis, liver cirrhosis and even hepatocellular carcinoma . |
| PubMedID- 21870716 | chronic infection with hepatitis c virus is nowadays responsible for many cases of liver disease. |
| PubMedID- 25596734 | Liver cancer incidence in humans, however, is significantly higher in men than in women , but the main risk factors of human liver cancer, including chronic infection with hepatitis viruses, cirrhosis, and exposure to aflatoxins, may mask the potential adverse effects of aromatic amines in this organ. |
| PubMedID- 22768303 | We formulated a model of immune tolerance during chronic infection with hepatitis b virus. |
| PubMedID- 21726511 | Background & aims: chronic infection with hepatitis b or c virus (hbv or hcv) is a leading cause of cirrhosis by unknown mechanisms of pathogenesis. |
| PubMedID- 22224076 | Sylvester chuks nwokediuko, department of medicine, university of nigeria teaching hospital, ituku ozallachronic infection with hepatitis b virus (hbv) is a global public health problem because of its worldwide distribution and its potential to cause sequelae. |
| PubMedID- 24713004 | chronic infection with hepatitis c virus (hcv) is a leading indicator for liver disease. |
| PubMedID- 24658127 | chronic infection with the hepatitis delta virus (hdv) is a risk factor for cirrhosis and hepatocellular carcinoma (hcc), but little is known whether the outcome of hepatitis is predicted by serum markers of hdv and hepatitis b virus (hbv) infection. |
| PubMedID- 20332260 | Background: chronic infection with hepatitis c virus (hcv) confers increased risk for chronic renal disease, and numerous reports suggest an association with renal cell carcinoma (rcc), a cancer with rapidly rising global incidence. |
| PubMedID- 20869253 | chronic infections with hepatitis b virus (hbv) and hepatitis c virus (hcv) lead to serious liver diseases worldwide. |
| PubMedID- 22588556 | In the united states, known risk factors for liver cancer, the majority of which is hepatocellular carcinoma (hcc), include chronic infection with hepatitis b virus (hbv), chronic infection with hepatitis c virus (hcv) (davila et al, 2004; davila et al, 2011) and excessive alcohol consumption (bosetti et al, 2007). |
| PubMedID- 21576430 | chronic infection with hepatitis c virus (hcv) is a major global health burden and is associated with an increased risk of liver cirrhosis and hepatocellular carcinoma. |